Mark S. Schmidt

4.7k total citations · 1 hit paper
45 papers, 2.4k citations indexed

About

Mark S. Schmidt is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Mark S. Schmidt has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Mark S. Schmidt's work include Calcium signaling and nucleotide metabolism (8 papers), Sirtuins and Resveratrol in Medicine (7 papers) and PARP inhibition in cancer therapy (6 papers). Mark S. Schmidt is often cited by papers focused on Calcium signaling and nucleotide metabolism (8 papers), Sirtuins and Resveratrol in Medicine (7 papers) and PARP inhibition in cancer therapy (6 papers). Mark S. Schmidt collaborates with scholars based in United States, United Kingdom and Germany. Mark S. Schmidt's co-authors include Charles Brenner, Samuel A.J. Trammell, Marie E. Migaud, Benjamin J. Weidemann, E. Dale Abel, Zhonggang Li, Ryan W. Dellinger, Frank Jaksch, Philip Redpath and Daryl J. Murry and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Mark S. Schmidt

44 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

2016 493 citations Samuel A.J. Trammell, Mark S. Schmidt et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Schmidt United States	21	698	666	590	474	444	45	2.4k
Shaohui Wang China	45	410 0.6×	2.8k 4.3×	621 1.1×	308 0.6×	144 0.3×	162	5.2k
Katrina L. Bogan United States	8	907 1.3×	701 1.1×	288 0.5×	507 1.1×	582 1.3×	8	1.9k
Marco Parenti Italy	40	221 0.3×	2.7k 4.1×	715 1.2×	286 0.6×	162 0.4×	161	5.2k
Gillian Mackay United Kingdom	33	90 0.1×	2.8k 4.3×	579 1.0×	532 1.1×	143 0.3×	54	5.0k
Andreas H. Guse Germany	41	285 0.4×	1.7k 2.6×	244 0.4×	493 1.0×	3.1k 7.1×	174	5.3k
Yuliang Ma United States	36	134 0.2×	3.8k 5.7×	711 1.2×	467 1.0×	116 0.3×	58	5.3k
James J. Galligan United States	31	133 0.2×	2.2k 3.3×	734 1.2×	185 0.4×	155 0.3×	90	3.7k
Benjamin R. Underwood United Kingdom	19	157 0.2×	1.8k 2.7×	653 1.1×	110 0.2×	259 0.6×	75	4.1k
Tomáš Obšil Czechia	33	67 0.1×	3.1k 4.7×	178 0.3×	197 0.4×	558 1.3×	97	4.0k
Ken Nakamura Japan	34	136 0.2×	2.7k 4.1×	1.5k 2.5×	226 0.5×	130 0.3×	116	6.1k

Countries citing papers authored by Mark S. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Mark S. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Schmidt more than expected).

Fields of papers citing papers by Mark S. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Schmidt. The network helps show where Mark S. Schmidt may publish in the future.

Co-authorship network of co-authors of Mark S. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Schmidt. A scholar is included among the top collaborators of Mark S. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Schmidt. Mark S. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

SenGupta, Tanima, Sini Pirnes-Karhu, Mark S. Schmidt, et al.. (2024). Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease. Heliyon. 10(14). e34355–e34355. 3 indexed citations

Schmidt, Mark S., et al.. (2024). Electrocortical Correlates of Emotion Processing and Resilience in Individuals with Adverse Childhood Experiences. Journal of Child & Adolescent Trauma. 17(3). 1–16. 2 indexed citations

Zhang, Quan‐Jiang, Zhonggang Li, Qiuxia Li, et al.. (2024). Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function. The EMBO Journal. 43(3). 362–390. 15 indexed citations

Orr, Miranda E., Paulino Ramirez, Qianqian Liu, et al.. (2023). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 46(1). 665–682. 18 indexed citations

Heer, Collin D., Yousef M. Alhammad, Mark S. Schmidt, et al.. (2020). Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. Journal of Biological Chemistry. 295(52). 17986–17996. 137 indexed citations

Levine, Daniel C., Hee‐Kyung Hong, Benjamin J. Weidemann, et al.. (2020). NAD+ Controls Circadian Reprogramming through PER2 Nuclear Translocation to Counter Aging. Molecular Cell. 78(5). 835–849.e7. 127 indexed citations

Matasic, Daniel S., Jin‐Young Yoon, Jared M. McLendon, et al.. (2020). Modulation of the cardiac sodium channel NaV1.5 peak and late currents by NAD+ precursors. Journal of Molecular and Cellular Cardiology. 141. 70–81. 12 indexed citations

Fons, Nathan R., Ranjini K. Sundaram, G. Breuer, et al.. (2019). PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nature Communications. 10(1). 3790–3790. 51 indexed citations

Ear, Po Hien, Ankita Chadda, Serena B. Gumusoglu, et al.. (2019). Maternal Nicotinamide Riboside Enhances Postpartum Weight Loss, Juvenile Offspring Development, and Neurogenesis of Adult Offspring. Cell Reports. 26(4). 969–983.e4. 51 indexed citations

10.

Dollerup, Ole L., Britt Christensen, Mads Svart, et al.. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. American Journal of Clinical Nutrition. 108(2). 343–353. 191 indexed citations

11.

Zhang, Hefei, Mark S. Schmidt, Daryl J. Murry, & Maureen D. Donovan. (2011). Permeation and Systemic Absorption of R- and S-Baclofen Across the Nasal Mucosa. Journal of Pharmaceutical Sciences. 100(7). 2717–2723. 6 indexed citations

12.

Murry, Daryl J., et al.. (2007). Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity. Heart Rhythm. 4(5). 629–637. 9 indexed citations

13.

Naik, Himanshu, et al.. (2007). Development and validation of a liquid chromatography–mass spectrometry assay for the determination of pyronaridine in human blood for application to clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 45(1). 112–119. 13 indexed citations

14.

Naik, Himanshu, et al.. (2007). Development and validation of a liquid chromatography–mass spectrometry assay for the determination of pyronaridine in human urine. Journal of Chromatography B. 853(1-2). 80–87. 5 indexed citations

15.

Schmidt, Mark S., Thomas E. Prisinzano, Kevin Tidgewell, et al.. (2005). Determination of Salvinorin A in body fluids by high performance liquid chromatography–atmospheric pressure chemical ionization. Journal of Chromatography B. 818(2). 221–225. 52 indexed citations

16.

Schmidt, Matthew, Mark S. Schmidt, Eduardo R. Butelman, et al.. (2005). Pharmacokinetics of the plant-derived κ-opioid hallucinogen salvinorin A in nonhuman primates. Synapse. 58(3). 208–210. 63 indexed citations

17.

Tidgewell, Kevin, Wayne W. Harding, Mark S. Schmidt, et al.. (2004). A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A. Bioorganic & Medicinal Chemistry Letters. 14(20). 5099–5102. 56 indexed citations

18.

Schmidt, Mark S., Per Torp Sangild, J.W. Blum, J.B. Andersen, & T. Greve. (2003). Combined ACTH and glucocorticoid treatment improves survival and organ maturation in premature newborn calves. Theriogenology. 61(9). 1729–1744. 27 indexed citations

19.

Malone, David M., Mark S. Schmidt, & Leonard W. Poon. (1998). THE DISTANCE LEARNING PARTNERSHIP IN GERONTOLOGY: THE GEORGIA MODEL FOR GERONTOLOGY HIGHER EDUCATION. Educational Gerontology. 24(3). 247–264. 11 indexed citations

20.

McDaniel, William F., et al.. (1991). The behavioral effects of bilateral middle cerebral artery hemorrhagic ischemia in rat. Neuroreport. 2(11). 699–702. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact